LANTHEUS HOLDINGS INC

Lantheus to Present at the William Blair 44th Annual Growth Stock Conference

28 مايو 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Lantheus Announces Executive Appointments to Accelerate Innovation

15 مايو 2024 15:30:00 بحسب Nasdaq GlobeNewswire

Lantheus Reports First Quarter 2024 Financial Results

02 مايو 2024 06:00:01 بحسب Nasdaq GlobeNewswire

Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time

18 أبريل 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024

05 مارس 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients

04 مارس 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Lantheus Announces Promotion of Amanda Morgan to Chief Commercial Officer

28 فبراير 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Lantheus to Present at the TD Cowen 44th Annual Health Care Conference

26 فبراير 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Lantheus Reports Fourth Quarter and Full Year 2023 Financial Results

22 فبراير 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Lantheus Announces Collaboration to Provide Novel Tau Imaging Agent for Large Consortium Clinical Trial Sponsored by the National Institute on Aging

13 فبراير 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Lantheus to Host Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast on February 22, 2024, at 8:00 a.m. Eastern Time

08 فبراير 2024 07:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: LANTHEUS HOLDINGS INC. - COMMON STOCK

23 يناير 2024 08:45:39 بحسب NetDania Notify

Lantheus Announces CEO Succession Plan

23 يناير 2024 06:45:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: LANTHEUS HOLDINGS INC. - COMMON STOCK

19 يناير 2024 11:25:48 بحسب NetDania Notify

Lantheus Announces Acceptance of its First-to-File ANDA for Generic LUTATHERA® (Lutetium Lu 177 Dotatate)

11 يناير 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective Therapeutics

09 يناير 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Lantheus Reports Preliminary Fiscal Year 2023 Revenue

09 يناير 2024 06:55:00 بحسب Nasdaq GlobeNewswire

Lantheus to Present at the 42nd Annual J.P. Morgan Healthcare Conference

03 يناير 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer

18 ديسمبر 2023 06:30:00 بحسب Nasdaq GlobeNewswire

Lantheus to Present at the Jefferies London Healthcare Conference

08 نوفمبر 2023 07:00:00 بحسب Nasdaq GlobeNewswire